Background
==========

*Staphylococcus aureus* enterotoxins acting as superantigens are known biological factors amplifying the pro-inflammatory patterns of upper airway inflammatory diseases, specifically chronic rhinosinusitis with nasal polyposis (CRSwNP) \[[@B1],[@B2]\]. Recently, it has been demonstrated that bacterial infection and viral superantigens may lead to epigenetic deregulations affecting host cell functions \[[@B3]\]. This study aimed to investigate the potential of *S. aureus* enterotoxin B (SEB) to induce changes in the gene DNA methylation pattern in inflamed nasal tissue.

Subjects and methods
--------------------

A detailed description of the procedures followed in the study is provided in the Additional file [1](#S1){ref-type="supplementary-material"}. Briefly, nasal polyp tissues from 3 patients with chronic rhinosinusitis and nasal polyposis were fragmented and homogenized as described previously \[[@B4]\] and subsequently cultured during 24 h in the absence or presence of 0,5 μg/ml of SEB (Sigma-Aldrich, MO, United States). After stimulation, genomic DNA was isolated and used for a whole genome methyl-CpG-binding domain2 (MBD2)- based DNA methylation analysis \[[@B5]\]. The sequence reads obtained were then mapped using BOWTIE \[[@B6]\] and the data were summarized using a MethylCap kit specific "Map of the Human Methylome" (<http://www.biobix.be>) containing 1,518,879 potentially methylated sites termed methylation cores (MCs) as shown in Figure [1](#F1){ref-type="fig"}. Methylation was defined as the peak coverage in the MCs and was analyzed with the software package \"R\" version 2.11.1.

![**Example of the visual representation of the results from MBD2 DNA methylation based analysis.** The figure shows the methylation cores (MC) for the differentially methylated region (exon 22) of the gene IKBKB on the genome browser \"The Hitchhiker's guide to the Genome\" (<http://www.biobix.be>). The height of the black peaks shows the methylation level in that specific region in samples cultured in medium and with staphylococcal enterotoxin B (SEB).](1710-1492-9-48-1){#F1}

Results
=======

A summary of the methylation data and analysis is provided in the repository file 1. In order to identify the genes which methylation status was affected by SEB stimulation, the obtained methylation cores (MCs) were ranked by "Likelihood Treatment" in descending order and an arbitrary \"cut-off\" was applied to select the 200 top differentially methylated genes. This ranking showed that stimulation with SEB mainly resulted in *de novo* hypermethylation (130 MCs) rather than in hypomethylation (70 MCs) and as expected, the methylation changes mainly occurred at intragenic regions (introns and exons) and to a lesser extend at the promoter or transcription start sites, as there were many more exonic and intronic MCs than promoter MCs in the entire map (Figure [2](#F2){ref-type="fig"}).

![**Distribution of the genomic regions showing differential methylation cores.** The figure shows the percentage of genes showing different methylation cores in nasal polyp tissue cultures stimulated with *S. aureus* enterotoxin B (SEB) when compared with non-stimulated tissue. Most of the methylation changes occurred in intragenic regions (exons and introns) and in less extend at the promoter genes site.](1710-1492-9-48-2){#F2}

The 200 MCs primarily selected were then filtered using a "Likelihood Treatment" cut-off of 0.4 or more which translates to an estimated 40% probability that the MC is differentially methylated between samples treated or not with SEB. This cut-off value was used due to the low likelihood treatment values and low confidence obtained as result of the low coverage. This process provided a list of 43 genes exhibiting changes in the methylation state after 24 h culture with SEB (Table [1](#T1){ref-type="table"}). From this list, 33 genes were hypermethylated while 10 genes showed hypomethylation. Three genes showed hypermethylations at promoter regions, and 18 and 12 genes at the intron and exon regions, respectively. Hypomethylation events were less frequent and they occurred at exonic regions in 9 genes, at introns in 1 gene and none at the promoter site (Table [1](#T1){ref-type="table"}). Additionally, changes in the methylation status in other regions of these genes were also observed, but they did not pass the likelihood treatment cut-off due to low coverage; this may be solved in future studies as high coverage becomes affordable due to declining sequencing costs.

###### 

Genes with different methylation status after stimulation with SEB

   **Methylation status**   **Location**    **Gene**    **Chr**   **Likelihood**   **Ensemble accession**   **Methylation score TCM**   **Methylation score SEB**
  ------------------------ -------------- ------------ --------- ---------------- ------------------------ --------------------------- ---------------------------
      Hypermethylation        Promoter       CTSLL2       10         0.599515         ENSG00000224036                   1                           7
                                             Y_RNA         6         0.595036         ENSG00000201555                   1                           8
                                           AC022026.3     10         0.589686         ENSG00000213731                   0                           6
                               Intron         CHD5         1         0.887026         ENSG00000116254                   0                           8
                                             STAB2        12         0.644866         ENSG00000136011                   1                           8
                                             ROBO1         3         0.53597          ENSG00000169855                   0                           5
                                             AJAP1         1         0.512208         ENSG00000196581                   1                           6
                                             TTLL1        22          0.4962          ENSG00000100271                   0                           4
                                             GLT1D1       12         0.472979         ENSG00000151948                   1                           8
                                             MAD1L1        7         0.47049          ENSG00000002822                   0                           5
                                            HEATR5B        2          0.4673          ENSG00000008869                   0                           4
                                              LGMN        14         0.459486         ENSG00000100600                   0                           5
                                             FAM59A       18         0.458542         ENSG00000141441                   0                           4
                                             STAT5B       17         0.458148         ENSG00000173757                   0                           5
                                              NKD1        16         0.457063         ENSG00000140807                   1                           7
                                            SLC25A24       1         0.431776         ENSG00000085491                   1                           7
                                           AC073343.1      7         0.430122         ENSG00000228010                   1                           6
                                            TMEM138       11         0.412654         ENSG00000149483                   1                           6
                                             MPRIP        17         0.411674         ENSG00000133030                   1                           7
                                              GAA         17         0.40881          ENSG00000171298                   1                           8
                                              RFX3         9         0.407894         ENSG00000080298                   1                           6
                                Exon        ADAMTS16       5         0.552893         ENSG00000145536                   1                          10
                                             IKBKB         8         0.533067         ENSG00000104365                   1                           7
                                             ZNF541       19         0.513317         ENSG00000118156                   1                           8
                                             KANK2        19         0.495541         ENSG00000197256                   0                           5
                                              CYBA        16         0.484142         ENSG00000051523                   0                           4
                                             UBE2I        16         0.471502         ENSG00000103275                   1                           6
                                             OLFM1         9         0.446344         ENSG00000130558                   1                           7
                                             MARK2        11         0.438781         ENSG00000072518                   1                           7
                                             CORO7        16         0.434694         ENSG00000103426                   1                           6
                                             KCNQ2        20         0.428704         ENSG00000075043                   1                           8
                                             ASAP1         8         0.414992         ENSG00000153317                   1                           6
                                             NOC2L         1         0.412654         ENSG00000188976                   1                           6
      Hypomethylation          Intron        POLR3E       16         0.647331         ENSG00000058600                   4                           0
                                             VPS13B        8         0.576756         ENSG00000132549                   4                           0
                                            ANKRD13A      12         0.520639         ENSG00000076513                   4                           0
                                             ZBTB20        3         0.491524         ENSG00000181722                   4                           0
                                           AC087393.2     17         0.44588          ENSG00000233098                   5                           1
                                             ZDHHC1       16         0.440425         ENSG00000159714                   3                           0
                                             PDZD2         5         0.440425         ENSG00000133401                   3                           0
                                             DLGAP2        8         0.423913         ENSG00000198010                   5                           1
                                             NDST1         5         0.405485         ENSG00000070614                   3                           0
                                Exon       AC016907.1      2         0.493142         ENSG00000233862                   3                           0

The table shows the nasal polyp tissue genes and locations undergoing methylation changes (hypermethylation and hypomethylation) with a likelihood treatment \> 0.4) after stimulation with SEB. Methylation score refers to the average methylation of the 3 samples in each experimental group. TCM: tissue culture medium or no stimulated cells, SEB: cells stimulated with S. aureus enterotoxin B.

These 43 top ranking genes were then selected for enrichment analysis in the Reactome database using the overrepresentation pathway analysis \[[@B7]\]. This algorithm delivered a list of "Statistically over-represented pathways" which represents all Reactome pathways containing proteins from the input gene list. This analysis resulted in 17 pathways (Table [2](#T2){ref-type="table"}) containing 6 potentially affected genes (STA5B, IKBKB, STAB2, NDST1, LGMN and CYBA). Based on previously published data regarding host-cellular immune responses to bacterial exotoxins we selected three main pathways (Table [3](#T3){ref-type="table"}) containing the genes: STAT5B, IKBKB, POLR3 and LGMN. These genes regulate processes influencing the response of cells to superantigens according to the biological function obtained in UniProt and the Reactome databases (Table [3](#T3){ref-type="table"}).

###### 

Biological pathway analysis of the 43 top ranked genes showing differential methylation after simulation with SEB

   ***P-value***   **Number of genes mapping the pathway**   **Total number of genes in the pathway**   **Pathway identifier**                 **Pathway name**                 **Genes mapping to the pathway**
  --------------- ----------------------------------------- ------------------------------------------ ------------------------ ---------------------------------------------- ----------------------------------
       0,004                          2                                         58                           REACT_118823        Cytosolic sensors of pathogen-associated DNA            IKBKB, POLR3E
       0,012                          2                                        110                           REACT_22232                  Signaling by interleukins                      STAT5B, IKBKB
       0,013                          2                                        115                            REACT_6966                 Toll-like receptors cascades                     LGMN, IKBKB
       0,015                          2                                        120                           REACT_121315                Glycosaminoglycan metabolism                     STAB2, NDST1
       0,015                          2                                        120                           REACT_147739                 MPS IX - Natowicz syndrome                      STAB2, NDST1
       0,015                          2                                        120                           REACT_147853                   Mucopolysaccharidoses                         STAB2, NDST1
       0,015                          2                                        120                           REACT_147788              MPS IIIB - Sanfilippo syndrome B                   STAB2, NDST1
       0,015                          2                                        120                           REACT_147719              MPS VI - Maroteaux-Lamy syndrome                   STAB2, NDST1
       0,015                          2                                        120                           REACT_147825                MPS IV - Morquio syndrome A                      STAB2, NDST1
       0,015                          2                                        120                           REACT_147860              MPS IIIC - Sanfilippo syndrome C                   STAB2, NDST1
       0,015                          2                                        120                           REACT_147759                   MPS VII - Sly syndrome                        STAB2, NDST1
       0,015                          2                                        120                           REACT_147734                  MPS II - Hunter syndrome                       STAB2, NDST1
       0,015                          2                                        120                           REACT_147857                  MPS I - Hurler syndrome                        STAB2, NDST1
       0,015                          2                                        120                           REACT_147749              MPS IIID - Sanfilippo syndrome D                   STAB2, NDST1
       0,015                          2                                        120                           REACT_147753              MPS IIIA - Sanfilippo syndrome A                   STAB2, NDST1
       0,015                          2                                        120                           REACT_147798                MPS IV - Morquio syndrome B                      STAB2, NDST1
       0,045                          4                                        915                           REACT_116125                          Disease                         STAT5B, STAB2, NDST1, CYBA

All genes used in the analysis showed a likelihood of treatment related effect \> 0,4. *P*-*value*: un-adjusted, not corrected for multiple testing, representing the probability (from hypergeometric test) of finding a given number or more genes in each pathway by chance.

###### 

**Sub**-**pathways and biological functions of the most representative genes showing hyper**-**methylation after stimulation with SEB**

    **Gene**    **UniProt**                 **Pathway name**                                **Sub-pathways**                                                                                                                                                                                                                                                  **Biological function**
  ------------ ------------- ---------------------------------------------- ------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
   **IKBKB**      O14920      Cytosolic sensors of pathogen-associated DNA    ZBP1 mediated induction of type I Interferons    Serine kinase that plays an essential role in the NF-kappa-B signaling pathway which is activated by multiple stimuli such as inflammatory cytokines, bacterial or viral products, DNA damages or other cellular stresses. It is involved in the transcriptional regulation of genes involved in immune response, growth control, or protection against apoptosis. May prevent the overproduction of inflammatory mediators since they exert a negative regulation on canonical IKKs.
                                       Adaptative immune response                             TCR signaling                                                                                                                                                                                                                                                               
                                       Signaling by interleukins                             IL-1 signaling                                                                                                                                                                                                                                                               
                                      Toll-Like receptors cascades           TLR2, TLR3, TLR5, TLR6, TLR7, TLR8, TLR9, TLR10                                                                                                                                                                                                                                              
   **POLR3E**     Q9NVU0      Cytosolic sensors of pathogen-associated DNA      Transcription of microbial dsDNA to dsRNA                                   Plays a key role in sensing and limiting infection by intracellular bacteria and DNA viruses. Acts as nuclear and cytosolic DNA sensor involved in innate immune response. Can sense non-self dsDNA that serves as template for transcription into dsRNA. The non-self RNA polymerase III transcripts, such as Epstein-Barr virus-encoded RNAs (EBERs) induce type I interferon and NF- Kappa-B through the RIG-I pathway.
   **STAT5B**     P51692               Signaling by interleukins              Signaling of IL-2, IL-3, IL-5, IL-7 and GMCSF                                                                                                                             Carries out a dual function: signal transduction and activation of transcription. Mediates cellular responses to the cytokine KITLG/SCF and other growth factors. Binds to the GAS element and activates PRL-induced transcription.
    **LGMN**      Q99538              Toll-Like receptors cascades             Trafficking and processing of endosomal TLR                                                                                                                                                                                     It is involved in the processing of proteins for MHC class II antigen presentation in the lysosomal/endosomal system.

The genes for this analysis were selected from the Reactome over-representation pathway analysis.

This study did not include healthy nasal mucosa. We specifically investigated whether *S. aureus* enterotoxin B might influence the gene DNA methylation pattern in inflamed (nasal polyp) tissue without studying the effects of the diseased status itself. Indeed, validation experiments including a larger number of samples as well as samples from control (healthy) tissue are warrented in light of these preliminary results. Also we could not preclude effects of other staphylococcal superantigens or superantigens from other germs as the nose is a hotspot of micro-organism activity \[[@B8]\]. However, although methylation differences due to other enterotoxins are a distinct possibility, this should not affect the results as both SEB treated and untreated cells originated from the same patients. Only if significant concentrations of other enterotoxins were present in all 3 patients might this confound the results. In conclusion, these preliminary findings suggest DNA methylation as a possible mechanism by which superantigens may regulate immune function in the nasal mucosa.
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Description of the data: These files include more detailed information about the patient's characteristics, methodologies used and results obtained in the study.
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